Researchers develop AI-based strategy for discovering high-affinity antibody drugs

Scientists at University of California San Diego School of Medicine have developed an artificial intelligence (AI)-based strategy for discovering high-affinity antibody drugs.

Related Keywords

San Diego ,California ,United States ,University Of California San Diego ,Wei Wang ,Jonathan Parkinson ,Emily Henderson ,Nature Communications ,Drug Administration ,Uc San Diego School Of Medicine ,California San Diego School ,Senior Author ,Molecular Medicine ,Diego School ,Industry Focus ,Ryan Hard ,Antibodies ,Artificial Intelligence ,Amino Acid ,Ntibody ,Arthritis ,Dancer ,Covid 19 ,Drugs ,Machine Learning ,Medicine ,Pd L1 ,Protein ,Rheumatoid Arthritis ,Least ,